FIELD: medicine.
SUBSTANCE: method involves administering pancreatine and/or a digestive enzyme mixture acting like pancreatine, in addition to insulin therapy. The remedy is introduced at a dose of 40000 lipase units when eating and 20000 lipase units between food intakes. Enzyme treatment is carried out on the background of patient fecal elastase-1 level not exceeding 100 mcg/g of patient stool.
EFFECT: enhanced effectiveness of glycemia control.
4 cl, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SELECTING DIGESTIVE ENZYME PREPARATION SINGLE DOSE | 2006 |
|
RU2303998C2 |
| ENZYMES FOR PHARMACEUTICAL APPLICATION | 2005 |
|
RU2389504C2 |
| DIGESTIVE AGENT OF MICROBIAL ENZYMES | 2009 |
|
RU2429291C1 |
| PANCREATINE MICROPELLET NUCLEI TO BE ENTERO-SOLUBLE COATED | 2006 |
|
RU2408364C2 |
| MICROGRANULES CONTAINING PANCREATIN | 2019 |
|
RU2706003C1 |
| USE OF ENZYMES ACTIVE IN A WIDE RANGE OF pH VALUES AS MEDICINAL AGENTS FOR STIMULATING DIGESTION | 2016 |
|
RU2721708C2 |
| ORAL PHARMACEUTICAL COMPOSITIONS BASED ON PRODUCTS CONTAINING LIPASES, FIRST OF ALL PANCREATINE, AND SURFACTANTS | 2005 |
|
RU2381813C2 |
| METHOD OF TREATING DIABETES MELLITUS IN OUTCOME OF TOTAL DUODENOPANCREATECTOMY | 2023 |
|
RU2823874C1 |
| COMPOSITION CONTAINING COMBINATION OF AT LEAST ONE PROTEOLYTIC ENZYME AND AT LEAST ONE LIPOLYTIC ENZYME USED TO PREVENT TRIGLYCERIDE SYNTHESIS | 2011 |
|
RU2536295C2 |
| DIAGNOSTIC TECHNIQUE FOR EARLY DISORDERS OF CARBOHYDRATE METABOLISM IN PATIENTS WITH CHRONIC PANCREATITIS | 2023 |
|
RU2824803C1 |
